FindTrial
Sign In

Comparative Study of Two Anesthetic Regimens on Postoperative Fatigue Following vestibular schwannoma Resection via the Sigmoid Sinus Approach: Propofol-Remifentanil versus Ciprofol-Remifentanil

Comparative Study of Two Anesthetic Regimens on Postoperative Fatigue Following vestibular schwannoma Resection via the Sigmoid Sinus Approach: Propofol-Remifentanil versus Ciprofol-Remifentanil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097573
Enrollment
Unknown
Registered
2025-02-20
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vestibular schwannoma

Interventions

propofol+ remifentanil:propofol+ remifentanil infusion intraoperatively
ciprofol+ remifentanil:ciprofol+ remifentanil infusion intraoperatively

Sponsors

shanghai Eye & ENT hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: This study included patients undergoing elective vestibular schwannoma resection via the retrosigmoid approach in our hospital, aged 18 to 65 years, with an ASA classification of I to III.

Exclusion criteria

Exclusion criteria: Exclusion criteria: patients who refuse to participate in the study, those unable to independently cooperate with preoperative and postoperative assessments, those with a known allergy to propofol or ciprofol, and those with severe or poorly controlled mental disorders. Elimination criterion: failure to complete follow-up.

Design outcomes

Primary

MeasureTime frame
incidence fatigue on postoperative day 1( CHALDER>=16);—

Secondary

MeasureTime frame
incidence fatigue on postoperative day 3( CHALDER>=16);hemodynamic profiles;HADS SCORE;BIS value;anesthesia duration;—

Countries

China

Contacts

Public Contactshen xia

shanghai eye & ENT hospital, fudan university

shenxiash@fudan.edu.cn+86 136 1187 4118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026